Get the Weekly Intelligence Brief — top committee picks every Sunday.
MTD · NYSE · STOCK

Mettler Toledo (MTD) Stock Analysis

Healthcare Updated October 10, 2026
$1,550.83
52W $1023.05 – $1585.72
55/100
$31.32B
34.8
1.19
AI Committee Verdict
Watch
55/100
Conviction: Contested · 50% agreement · 6 analysts
-12.3%
Contested

Is MTD Bullish or Bearish?

Mixed. Innellis AI committee rates Mettler Toledo (MTD) Watch with a composite score of 55/100 , based on 6 analysts with 50% agreement. Last updated October 10, 2026.

What Would Change This View

Upgrade to Buy
Requires a committee score of 60.0 — +4.81 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Reduce
Requires the score to fall below 40.0 — -15.19 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Growth Analyst sees a compelling case — 5 consecutive earnings beats -- consistent execution. Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • ROE of 1816.3% shows genuine earnings power backing the valuation — Value
  • 5 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • P/E of 34.3 is moderate-to-rich — Value
  • Price-to-book of 1299.4x prices in significant intangible value — Value
  • Debt-to-equity of 81.23 adds balance-sheet risk to the value case — Value
  • Daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend — Technical
  • High leverage (debt-to-equity 81.23) amplifies downside in a stress scenario — Risk
  • Bollinger bandwidth of 20.8% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of October 10, 2026
Overall Committee Score
55/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 64%
of 192 Healthcare peers
Value Analyst neutral
45 / 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 1816.3% shows genuine earnings power backing the valuation
− P/E of 34.3 is moderate-to-rich
Growth Analyst bullish
68 / 100 · High confidence
Strong, accelerating growth with consistent execution
+ 5 consecutive earnings beats -- consistent execution
Technical Analyst neutral
59 / 100 · High confidence
Mixed or range-bound price action
+ Price structure making higher highs and higher lows
− Daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend
Risk Analyst bearish
32 / 100 · Moderate confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 81.23) amplifies downside in a stress scenario
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst bullish
62 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager bearish
30 / 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 55.2 to 55.2.

Analyst-level changes:
  • Risk Analyst: +1 bearish signal(s).
  • Value Analyst: +1 bearish signal(s).

Comparing 2026-10-09 to 2026-10-10 (1 day apart).

Technical Analysis

RSI (14)
68.8
Neutral
MACD Histogram
3.627
Bullish Momentum
Trend Direction
Uptrend
Weekly: Downtrend
Market Structure
Mixed
Bollinger %B
0.75
Inside Bands
Price vs Moving Averages
EMA 9
$1,521.20 Above
EMA 21
$1,481.81 Above
EMA 50
$1,424.04 Above
EMA 200
$1,334.81 Above

Fundamental Analysis

Valuation
10
Growth
74
Profitability
74
Financial Health
13
Cash Flow
70
Valuation
P/E Ratio 34.8×
P/B Ratio —
PEG Ratio 2.81
Dividend Yield 0.00%
52W High $1585.72
52W Low $1023.05
Quality & Growth
ROE —
ROA 2341.2%
Gross Margin 5835.2%
Operating Margin 2840.7%
Revenue Growth YoY —
Debt / Equity —
AI Fundamental Assessment
P/E ratio of 34.8 (rich relative to a 15-40x range); Price-to-book of 2432.2x; PEG ratio of 2.8 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -3677.4%; Return on assets of 23.4%; Net margin of 21.9%; Gross margin of 58.4%; Current ratio of 1.12 (tight short-term liquidity); Debt-to-equity of 164.70; Free cash flow per share is positive (42.94); Most recent quarter beat estimates by 5.2%; 5 consecutive earnings beats; EPS growth accelerating (-33.3% -> +28.6% QoQ); Average YoY EPS growth of 13.6%; Analyst estimates falling over recent quarters
Get the Full MTD Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime